Another Recall Concerning Inferior Drugs

Pharmaceutical recalls concerning the substandard production, size, dosage and quality of the product already within the domestic supply chain have proliferated recently within the United States.

These broad recalls seemingly demonstrate a broad lack of regulatory control and inspection at the point of manufacturing and import.

We believe that it is important that all of the members of the pharmaceutical supply chain engage in materials authentication and verification in order to protect their inventories from shoddy product that will impact the health of the consumer.


Caraco Recalls Generic Pills Over Irregular Sizes (Update1)

Caraco Pharmaceutical Laboratories Ltd. recalled generic heart tablets that may contain the wrong amount of medicine, sending the drugmaker down the most in four months in New York trading.

The voluntary recall covers 0.125 milligram and 0.25 milligram digoxin tablets distributed before today and within the expiration date of September 2011, according to statements released today by the company and the U.S. Food and Drug Administration. Size differences among the pills may mean they have too much or too little of the active ingredient.

The full article can be viewed on www.bloomberg.com.